Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 23, 2022
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
Mon, August 22, 2022
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
Marc Goodman Maintained (AXSM) at Buy with Increased Target to $75 on, Aug 22nd, 2022
Marc Goodman of SVB Leerink, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $50 to $75 on, Aug 22nd, 2022.
Marc has made no other calls on AXSM in the last 4 months.
There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Marc's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $55 on, Wednesday, August 10th, 2022
These are the ratings of the 3 analyists that currently disagree with Marc
- Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
- Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022
